Navigation Links
New Melanoma Drug May Extend Survival
Date:2/23/2012

By Steven Reinberg
HealthDay Reporter

WEDNESDAY, Feb. 22 (HealthDay News) -- Melanoma that has spread to other areas of the body is almost always fatal, but a new drug appears to double survival for those with a certain type of this skin cancer, researchers report.

A mutation in the BRAF protein occurs in about half the people who develop melanoma. Researchers say Zelboraf (vemurafenib), a drug approved by the U.S. Food and Drug Administration in 2011, blocks that mutation, thereby killing the cancer cells.

"We demonstrated in a large group of patients overall survival approached 16 months, which is far beyond what we have seen in other trials," said lead researcher Dr. Jeffrey Sosman, a professor of medicine at the Vanderbilt-Ingram Cancer Center in Nashville, Tenn.

Survival for people with advanced melanoma is usually six to 10 months. Some new drugs have extended that to maybe 11 months, "but this is the first time we have shown such a long extension in survival," he said.

All of the patients had late-stage (stage 4) melanoma. Sosman said it's hoped that Zelboraf will work even better when given sooner.

"If we use it in an earlier stage, then we are hoping to cure patients who would not be cured otherwise," he said.

Results of this phase 2 trial -- undertaken to assess the effectiveness and safety of the drug -- are published in the Feb. 23 issue of the New England Journal of Medicine.

For more than a year, Sosman's team followed 132 patients with previously treated metastatic melanoma, meaning the cancer had spread and was considered inoperable.

Zelboraf is a pill that patients take twice a day, and more than half who took the drug responded to it, the researchers said.

A response meant more than a 30 percent reduction in the size of tumors. Only 14 percent of patients failed to show any response to Zelboraf whatsoever, meaning their disease continued to progr
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Scanning for skin cancer: Infrared system looks for deadly melanoma
2. Non-Melanoma Skin Cancers in the Millions and Rising
3. Late-stage melanoma results in economic burden
4. Clinical trial to test whether vaccine can effectively treat melanoma
5. Wistar scientists explain the persistence of melanoma through dynamic stemness
6. Tanning Beds Can Greatly Boost Melanoma Risk
7. U of M study definitively links indoor tanning to melanoma
8. Indoor Tanning Beds Increase Risk of Melanoma
9. Novel Drug Combats Advanced Melanoma
10. Combination treatment regimen not effective against advanced melanoma
11. New treatment method safe, effective for advanced melanoma patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Melanoma Drug May Extend Survival 
(Date:8/28/2014)... Twenty seven per cent of rheumatoid arthritis patients in ... known as anti-TNF therapies did not take them as ... Royal Infirmary were among those from 60 hospitals around ... the Arthritis Research UK Centre for Genetics and Genomics ... warned that failure to take the drugs correctly, known ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 AmeriPride Services, ... America, today announced the launch of its new Customer ... AmeriPride even easier and more convenient for customers. The ... online and better communicate with the company. , Features ... Access, download and pay bills ...
(Date:8/28/2014)... Clarity PSO , an operating division of ... Patient Safety Organization (PSO) for another three-year period under ... Quality (AHRQ). Clarity PSO will continue to provide valuable ... true intentions of the Patient Safety and Quality Improvement ... eager to continue our journey as a PSO and ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 Genetic ... available throughout the world, with large reference laboratories ... Since laboratories differ with regard to the genetic ... costs, payers may struggle to find the most ... To help clients sort through these differences, Hayes, ...
(Date:8/28/2014)... veEDIS Clinical Systems, LLC has successfully ... in Lawrence Medical Center, located in Moulton, Alabama. ... patient care, veEDIS is a key ingredient in ... the authorized, confidential exchange of patient information at ... designed in accordance with clinical workflows and best ...
Breaking Medicine News(10 mins):Health News:Arthritis patients failing to take expensive medication, according to new research 2Health News:AmeriPride Services Launches New Customer Portal 2Health News:AmeriPride Services Launches New Customer Portal 3Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 2Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 3Health News:Hayes, Inc. Unveils Laboratory Comparison Tables for GTE Clients 2Health News:veEDIS Clinical Systems “Delivers,” as the 2014 Edition CEHRT Emergency Department EHR System is Implemented at Lawrence Medical Center 2Health News:veEDIS Clinical Systems “Delivers,” as the 2014 Edition CEHRT Emergency Department EHR System is Implemented at Lawrence Medical Center 3
... U.S. HIV/AIDS Atlas , , WASHINGTON, June 22 ... Atlas ( http://www.MapHIV.org ) that highlights ... United States. The Atlas makes information on HIV/AIDS prevalence ... painting a comprehensive picture of the varying intensity of the ...
... Hoag ... of Cardiology) as its executive medical director of the Hoag Heart and Vascular Institute (HHVI). ... Newport Beach, Calif. ... Tancredi, M.D., F.A.C.C. (Fellow of the American College of Cardiology) as its executive medical director ...
... Time for Fitness! , , LOS ANGELES, June 22 ... the park or along the beach. Now a brand new product ... equipment on wheels, but with a unique design to allow your ... new concept of fitness, will be introduced to California starting from ...
... study finds, , MONDAY, June 22 (HealthDay News) -- ... blood pressure, but new research finds those extra pounds can ... especially if she experiences early menopause. , Published in the ... found that women with a body-mass index (BMI) greater than ...
... CRO expertise in $1 billion market for cancer support ... , WATERTOWN, Mass., June 22 Biomodels LLC, ... today announced that its customized research program allowed ActoGeniX ... Food and Drug Administration (FDA) approval for Phase 1b ...
... LLC, the rising star of the Sports Nutrition Industry, ... each of Vitamin Shoppe,s 400+ locations nationwide. , ... of our entire line of products," MUSCLEPHARM president Brad ... in nearly every neighborhood across the nation! Vitamin Shoppe ...
Cached Medicine News:Health News:MapHIV.org Shows California's San Francisco County Seriously Impacted by HIV 2Health News:MapHIV.org Shows California's San Francisco County Seriously Impacted by HIV 3Health News:Nationally Acclaimed Cardiologist Joins Hoag Heart and Vascular Institute as Executive Medical Director 2Health News:Pumgo Fitness Scooter Will Highlight Venice Beach This Summer 2Health News:Obesity Greatly Raises Endometrial Cancer Risk 2Health News:Obesity Greatly Raises Endometrial Cancer Risk 3Health News:Biomodels' Oral Mucositis Expertise Speeds FDA Approval for ActoGeniX's Phase 1b Trial of AGO13 in Cancer Patients 2Health News:MUSCLEPHARM Products Hit Vitamin Shoppe Shelves With a Bang! 2
(Date:8/28/2014)... , Aug. 28, 2014 MGC Diagnostics Corporation ... a conference call to discuss its financial results for ... 2014. The call will be at 4:30 p.m. ET ... financial results for the third quarter of fiscal 2014 ... Participants can dial (877) 317-6789 or ...
(Date:8/28/2014)... SAN ANTONIO , Aug. 28, 2014 ... therapeutics for the treatment of cancer, announces the recent ... the journal Steroids . The recent ... below), reviews the evolution and development of GenSpera,s prodrug technology ... activity of thapsigargin (from the plant Thapsia garganica ...
(Date:8/28/2014)... 2014 Auxilium Pharmaceuticals, Inc. (NASDAQ: ... data from trials evaluating the use of collagenase clostridium histolyticum ... adult patients with a palpable cord will be presented at ... Society for Surgery of the Hand (ASSH) being held in ... ® (CCH) is a biologic approved in the U.S., ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Third Quarter Fiscal 2014 Financial Results on Tuesday, September 9, 2014 2GenSpera Media Advisory; "Targeting thapsigargin towards tumors" Published in Steroids 2GenSpera Media Advisory; "Targeting thapsigargin towards tumors" Published in Steroids 3Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting 2Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting 3Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting 4Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting 5Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting 6
... Cognizant (NASDAQ: CTSH ), a ... outsourcing services, today announced a multi-year agreement with ... services to generate clinical study reports. ... statistical programming, statistical analysis, medical writing, and document ...
... 29, 2011  Buffalo Heart Group, LLP, 2011 :  Today ... of the AngelMed Guardian cardiac monitor and alert system. The ... to get to the emergency room during an impending heart ... state of New York, and is among the very first ...
Cached Medicine Technology:Cognizant to Deliver Comprehensive Biostatistics and Medical Reporting Services for AstraZeneca 2Cognizant to Deliver Comprehensive Biostatistics and Medical Reporting Services for AstraZeneca 3Buffalo Heart Group Investigates Early Heart Attack Detection Device Developed By Angel Medical Systems 2
... The design of the Hi-Top ... to be held back in ... shoe counter. The front is ... and compression on the toes. ...
... semi-rigid post op shoe is ideal for ... breathable upper will keep your patient both ... closure provides even tension and compression. The ... support for your patient. The black TPR ...
Comfortably positions the affected foot at 90 to provide continuous and effective stretching of the plantar fascia and Achilles Tendon...
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
Medicine Products: